Emerging Pain Targets and Therapy
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 July 2012) | Viewed by 62113
Special Issue Editor
Interests: fibromyalgia; pain; potassium channels; drug design/discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pain remains a major clinical challenge with the management of pain the most frequent issue encountered by clinicians. Many current analgesics are limited by serious unwanted effects, while for some pain conditions there are no effective analgesics. Advances in molecular biological techniques that have enabled the discovery of specific molecules involved in pain production have contributed to a better understanding of pain and the mechanisms of different types of pain and are providing clues for the development of novel pharmacotherapies for specific pain types. This increased understanding of pain physiology has offered a number of potential targets (e.g. TRPV1, voltage-gated sodium channels, calcium channels, glutamate receptors, cannabinoids) for future treatments, in particular for neuropathic and chronic pain. This special issue is intended to provide the reader with an insight into the progress made in this field through novel contributions of original papers and critical reviews.
Dr. Kim Lawson
Guest Editor
Keywords
- pain
- pain pathways
- emerging targets
- molecular biology
- novel therapies
- ion channels
Related Special Issue
- New Advances in Pharmacological Targets for Pain in Pharmaceuticals (1 article)